Incidence and prevention of infective endocarditis and bacteraemia after transcatheter aortic valve implantation in a French university hospital: a retrospective study. Issue 1 (May 2018)

• Record Type: Journal Article
• Authors: Gallouche, M.; Barone-Rochette, G.; Pavese, P.; Bertrand, B.; Vanzetto, G.; Bouvaist, H.; Pierre, I.; Schmitt, D.; Fauconnier, J.; Caspar, Y.; Recule, C.; Picot-Guéraud, R.; Stahl, J.P.; Mallaret, M.R.; Landelle, C.
• Is Part Of: Journal of hospital infection. Volume 99:Issue 1(2018)
• Page Start: 94
• Page End: 97
• Publication Date: 2018-05
• Subjects: Transcatheter aortic valve implantation -- Infective endocarditis -- Bacteraemia -- Screening -- Decolonization -- Staphylococcus aureus; Cross infection -- Periodicals; Cross infection -- Prevention -- Periodicals; Nosocomial infections -- Periodicals; Nosocomial infections -- Prevention -- Periodicals; Cross Infection -- Periodicals; Cross Infection -- prevention & control -- Periodicals; Infection Control -- Periodicals; Electronic journals; 614.44
• DOI: 10.1016/j.jhin.2017.11.013
• Languages: English
• ISSNs: 0195-6701

Abstract

Summary: Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is a rare but severe complication. Among 326 patients who underwent TAVI at Grenoble Alpes University Hospital, six (1.8%) cases of IE and 11 (3.4%) cases of bacteraemia were identified. No cases of IE were linked to the intervention; one was due to Staphylococcus aureus despite a screening and targeted decolonization strategy. This underscores the need for randomized studies to evaluate the benefit and cost-effectiveness of this policy.